These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34188776)

  • 61. Biological Significance of the Genomic Variation and Structural Dynamics of SARS-CoV-2 B.1.617.
    Fan LQ; Hu XY; Chen YY; Peng XL; Fu YH; Zheng YP; Yu JM; He JS
    Front Microbiol; 2021; 12():750725. PubMed ID: 34691002
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Structural effects of spike protein D614G mutation in SARS-CoV-2.
    Dokainish HM; Sugita Y
    Biophys J; 2023 Jul; 122(14):2910-2920. PubMed ID: 36397671
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Conservative Replacement in the Transmembrane Domain of SARS-CoV-2 ORF7a as a Putative Risk Factor in COVID-19.
    Lobiuc A; Șterbuleac D; Sturdza O; Dimian M; Covasa M
    Biology (Basel); 2021 Dec; 10(12):. PubMed ID: 34943191
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants.
    Caputo E; Mandrich L
    Life (Basel); 2022 Aug; 12(8):. PubMed ID: 36013424
    [TBL] [Abstract][Full Text] [Related]  

  • 65. SARS-CoV-2 Variants: Mutations and Effective Changes.
    Park G; Hwang BH
    Biotechnol Bioprocess Eng; 2021; 26(6):859-870. PubMed ID: 34975266
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phylogenicity of B.1.1.7 surface glycoprotein, novel distance function and first report of V90T missense mutation in SARS-CoV-2 surface glycoprotein.
    Stojanov D
    Meta Gene; 2021 Dec; 30():100967. PubMed ID: 34466389
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Corrigendum: Decreased interfacial dynamics caused by the N501Y mutation in the SARS-CoV-2 S1 spike:ACE2 complex.
    Ahmed WS; Philip AM; Biswas KH
    Front Mol Biosci; 2022; 9():1018464. PubMed ID: 36339712
    [TBL] [Abstract][Full Text] [Related]  

  • 68. D614G mutation eventuates in all VOI and VOC in SARS-CoV-2: Is it part of the positive selection pioneered by Darwin?
    Chakraborty C; Saha A; Sharma AR; Bhattacharya M; Lee SS; Agoramoorthy G
    Mol Ther Nucleic Acids; 2021 Dec; 26():237-241. PubMed ID: 34484868
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Corrigendum: Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity.
    Tang H; Gao L; Wu Z; Meng F; Zhao X; Shao Y; Shi X; Qiao S; An J; Du X; Qin FX
    Front Cell Infect Microbiol; 2021; 11():813645. PubMed ID: 34912731
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Estimating the strength of selection for new SARS-CoV-2 variants.
    van Dorp CH; Goldberg EE; Hengartner N; Ke R; Romero-Severson EO
    medRxiv; 2021 Sep; ():. PubMed ID: 33821289
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival.
    Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
    Comput Struct Biotechnol J; 2021; 19():3864-3875. PubMed ID: 34109017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Emerging variants of concern in Saudi Arabian SARS-CoV-2 isolates.
    Al-Sehemi AG; Khan MT; Muhammad S
    Saudi Med J; 2021 Dec; 42(12):1366-1368. PubMed ID: 34853144
    [No Abstract]   [Full Text] [Related]  

  • 73. Evolution of SARS-CoV-2 mutational variants: Hysteria or hope for the future?
    Esmail A; Scott AJ; Dheda K
    Afr J Thorac Crit Care Med; 2021; 27(4):. PubMed ID: 35359692
    [No Abstract]   [Full Text] [Related]  

  • 74. [The evolution of SARS-CoV-2 variants and their clinical and healthcare implications].
    Eiros JM; Hernández M
    Rev Clin Esp; 2022; 222(7):414-416. PubMed ID: 35079173
    [No Abstract]   [Full Text] [Related]  

  • 75. Variants of SARS-CoV-2.
    Lauring AS; Malani PN
    JAMA; 2021 Aug; ():. PubMed ID: 34387645
    [No Abstract]   [Full Text] [Related]  

  • 76. Editorial: Computational Approaches to Foster Innovation in the Treatment and Diagnosis of Infectious Diseases.
    Lousa D; Soares CM; Barroso da Silva FL
    Front Med Technol; 2022; 4():841088. PubMed ID: 35187528
    [No Abstract]   [Full Text] [Related]  

  • 77. B cell persistence and evolution to SARS-CoV-2.
    Alrubayyi A
    Nat Rev Immunol; 2021 Jan; 21(1):3. PubMed ID: 33262448
    [No Abstract]   [Full Text] [Related]  

  • 78. Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses.
    Kannan SR; Spratt AN; Cohen AR; Naqvi SH; Chand HS; Quinn TP; Lorson CL; Byrareddy SN; Singh K
    J Autoimmun; 2021 Nov; 124():102715. PubMed ID: 34399188
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic.
    Otto SP; Day T; Arino J; Colijn C; Dushoff J; Li M; Mechai S; Van Domselaar G; Wu J; Earn DJD; Ogden NH
    Curr Biol; 2021 Jul; 31(14):R918-R929. PubMed ID: 34314723
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ongoing global and regional adaptive evolution of SARS-CoV-2.
    Rochman ND; Wolf YI; Faure G; Mutz P; Zhang F; Koonin EV
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34292871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.